AI Accelerates analysis. Competitive intelligence drives action.
As AI expands competitive signals, biopharma leaders need trusted intelligence to identify risks and opportunities.
AI helps life sciences organizations evaluate more opportunities, analyze more data and move faster than ever before. However, as Henry Levy, president of Life Sciences & Healthcare at Clarivate, explains, success depends on combining AI with trusted data, scientific expertise and human accountability. The organizations that gain a competitive advantage will not simply generate more insights; they will make better-informed decisions based on reliable intelligence and expert judgment. View the full interview, here.
